Title: Oncology Medical Science Liaison- Southeast
Location: Minneapolis, MN
Specialties: Oncology
Base: $170,000 - $200,000/yr
Bonus: Bonus and stock options
401k matching: 401(k) plan
The Oncology Medical Science Liaison serves as a key scientific resource providing medical and scientific education and support for Fennec's oncology product PEDMARK. Responsibilities include proactive and reactive scientific presentations to healthcare professionals, developing collaborative relationships with oncologists and key opinion leaders, supporting internal sales and marketing teams, and ensuring safe and effective use of the product. The role requires excellent communication skills, compliance with legal guidelines, and frequent travel.
Added on: 08/13/2025
About Fennec Pharmaceuticals:
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in pediatric patients. PEDMARK® received FDA approval in September 2022. European Commission approval was received in June 2023, and U.K. approval in October 2023 under the brand name PEDMARQSI®. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection. Fennec employees are expected to embrace diversity and be able to work with internal cross-functional colleagues as well as external partners from a variety of backgrounds and experiences. Additionally, the successful candidate must demonstrate excellence in integrity and compliance with all interactions and adherence to corporate and industry guidelines. Fennec offers a fun, friendly, and industry competitive environment.
Fennec employees are expected to embrace diversity and be able to work with internal and external partners from a variety of backgrounds, and experiences. Additionally, the successful candidate must demonstrate excellence in integrity and compliance with all interactions and adherence to corporate and industry guidelines. Fennec offers a fun, friendly, and industry competitive environment.
Position Summary:
We are looking for a smart, mission-oriented Medical Affairs professional who can communicate effectively and help Fennec transform the management ototoxicity in patients receiving cisplatin chemotherapy. This MSL, will report into Medical Affairs leadership, and will serve as a key field-based scientific resource for clinicians, academic institutions, professional organizations and patients and caregivers. This individual will be responsible for providing medical/scientific education and support for Fennec’s oncology product. The North Central MSL will demonstrate scientific, clinical and therapeutic area expertise by providing timely medical information/education in support of fair-balanced scientific exchange with oncologists, and additional relevant HCPs. This MSL will also be able to provide appropriate training on the safe administration and dosing of Fennec products and has the overall, goal of ensuring the safe and effective use of PEDMARK.
Responsibilities
The primary responsibilities of the Southeast MSL are to:
Professional Experience/Qualifications
Fennec Pharmaceutical Compensation and Benefits Summary
We understand compensation is an important factor as you consider the next step in your career. Below is an overview of the compensation and benefits offerings.
Base Salary Range:
$170,000-$200,000
The estimated salary range reflects an anticipated range for this position. The actual base salary offered may depend on a variety of factors, including the qualifications of the individual applicant for the position, years of relevant experience, specific and unique skills, level of education attained, certifications or other professional licenses held.
Employees may be eligible to participate in medical, dental, vision insurance, a 401(k) plan, short-term and long-term disability coverage, basic life insurance, company holidays, vacation, cell phone and WiFi reimbursement, a bonus, and stock options.